October 16, 2018
Teva Pharmaceuticals International GmbH and Eagle Pharmaceuticals Inc. have challenged two drugmakers' applications to make generic versions of a chemotherapy drug, claiming in a lawsuit filed Monday in Delaware federal court that the generics would rip off two of Eagle's patents.